| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Medical Research Center for Cancer Molecular Therapy and Department of Biochemistry, College of Medicine, Dong-A University, Busan, Korea;
Sigmol, Pohang, Korea;
Department of Pharmacology, University of Illinois, Chicago, IL 60612; and
Division of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang, Korea
Formyl peptide receptor-like 1 (FPRL1) plays a key role in the regulation of immune responses. The activation of FPRL1 induces a complicated pattern of cellular signaling, which results in the regulation of several immune responses, such as chemotactic migration and the production of reactive oxygen species (ROS). Because some of these cellular responses are not beneficial to the host, ligands that selectively modulate these cellular responses are useful. His-Phe-Tyr-Leu-Pro-Met (HFYLPM) is a synthetic peptide that binds to FPRL1. In this study, we generated various HFYLPM analogues and examined their effects on cellular responses via FPRL1 in FPRL1-expressing rat basophilic leukemia-2H3 cells or in primary human neutrophils. Among the HXYLPM analogues, His-Arg-Tyr-Leu-Pro-Met (HRYLPM) activated a broad spectrum of cellular signaling events, including an intracellular Ca2+ concentration increase, phosphoinositide 3-kinase, extracellular signal-regulated kinase, and Akt activation, however, His-Glu-Tyr-Leu-Pro-Met (HEYLPM) activated only intracellular Ca2+ concentration and Akt but did not increase Ca2+. In addition, HRYLPM was found to stimulate chemotaxis and ROS generation via phosphoinositide 3-kinase and an intracellular Ca2+ concentration increase, respectively, whereas HEYLPM stimulated chemotaxis but not ROS generation. With respect to the molecular mechanisms involved in the differential action of HRYLPM and HEYLPM, we found that HRYLPM but not HEYLPM competitively inhibited the binding of 125I-labeled Trp-Lys-Tyr-Met-Val-D-Met-NH2 (WKYMVm, a FPRL1 ligand) to FPRL1. This study demonstrates that the important chemoattractant receptor, FPRL1, may be differentially modulated by distinct peptide ligands. We also suggest that HRYLPM and HEYLPM may be used to selectively modulate FPRL1.
This article has been cited by other articles:
|
|
 |
|
  S. D. Kim, J. M. Kim, S. H. Jo, H. Y. Lee, S. Y. Lee, J. W. Shim, S.-K. Seo, J. Yun, and Y.-S. Bae Functional Expression of Formyl Peptide Receptor Family in Human NK Cells J. Immunol., November 1, 2009; 183(9): 5511 - 5517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhou, S. Zhang, M. Nanamori, Y. Zhang, Q. Liu, N. Li, M. Sun, J. Tian, P. P. Ye, N. Cheng, et al. Pharmacological Characterization of a Novel Nonpeptide Antagonist for Formyl Peptide Receptor-Like 1 Mol. Pharmacol., October 1, 2007; 72(4): 976 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Y. Lee, M.-K. Kim, K. S. Park, E. H. Shin, S. H. Jo, S. D. Kim, E. J. Jo, Y.-N. Lee, C. Lee, S.-H. Baek, et al. Serum Amyloid A Induces Contrary Immune Responses via Formyl Peptide Receptor-Like 1 in Human Monocytes Mol. Pharmacol., July 1, 2006; 70(1): 241 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Park, H.-Y. Lee, M.-K. Kim, E. H. Shin, S. H. Jo, S. D. Kim, D.-S. Im, and Y.-S. Bae Lysophosphatidylserine Stimulates L2071 Mouse Fibroblast Chemotactic Migration via a Process Involving Pertussis Toxin-Sensitive Trimeric G-Proteins Mol. Pharmacol., March 1, 2006; 69(3): 1066 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Shaykhiev, C. Beisswenger, K. Kandler, J. Senske, A. Puchner, T. Damm, J. Behr, and R. Bals Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L842 - L848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Simoes and I. M. Fierro Involvement of the Rho-Kinase/Myosin Light Chain Kinase Pathway on Human Monocyte Chemotaxis Induced by ATL-1, an Aspirin-Triggered Lipoxin A4 Synthetic Analog J. Immunol., August 1, 2005; 175(3): 1843 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Kang, H.-Y. Lee, M.-K. Kim, K. S. Park, Y. M. Park, J.-Y. Kwak, and Y.-S. Bae The Synthetic Peptide Trp-Lys-Tyr-Met-Val-D-Met Inhibits Human Monocyte-Derived Dendritic Cell Maturation via Formyl Peptide Receptor and Formyl Peptide Receptor-Like 2 J. Immunol., July 15, 2005; 175(2): 685 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Jo, H.-Y. Lee, Y.-N. Lee, J. I. Kim, H.-K. Kang, D.-W. Park, S.-H. Baek, J.-Y. Kwak, and Y.-S. Bae Group IB Secretory Phospholipase A2 Stimulates CXC Chemokine Ligand 8 Production via ERK and NF-{kappa}B in Human Neutrophils J. Immunol., November 15, 2004; 173(10): 6433 - 6439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-S. Bae, H. Y. Lee, E. J. Jo, J. I. Kim, H.-K. Kang, R. D. Ye, J.-Y. Kwak, and S. H. Ryu Identification of Peptides That Antagonize Formyl Peptide Receptor-Like 1-Mediated Signaling J. Immunol., July 1, 2004; 173(1): 607 - 614. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
